NextBio offers the life sciences enterprise secure data access, knowledge discovery and collaboration tools, and enterprise integration capabilities for seamless correlation of internal research data.
Saeid Akhtari, co-founder and CEO of NextBio, said: “We are pleased Merck has chosen NextBio as a drug discovery and development partner. Merck’s adoption of the NextBio solution validates our approach to solving the information bottleneck currently impacting research-driven pharmaceutical and biotechnology companies worldwide. We look forward to further building and extending our relationship with Merck’s researchers over the coming years.”